Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Armstrong

Showing results (11-20 of 120) with videos related to

Pageof 12
Sort By:
Gastroenterology|September 27, 2017
Dysphagia: More Than Meets the Eye?Matthew J Armstrong, Ruhina Ahmed, Ralph Boulton
Lancet (London, England)|June 18, 2016
Liraglutide for patients with non-alcoholic steatohepatitis - Authors' replyPhilip N Newsome, Matthew J Armstrong, Piers Gaunt
Hepatology (Baltimore, Md.)|June 12, 2016
Identifying patients with nonalcoholic steatohepatitis that are nonresponders to therapyMatthew J Armstrong, Piers Gaunt, Philip N Newsome
BJGP Open|December 21, 2023
How to address the inverse care law and increase GP recruitment in areas of socioeconomic deprivation: a qualitative study of GP trainees' views and experiences in the UKMatthew J Armstrong, Josephine M Wildman, Sarah Sowden
Current Opinion in Gastroenterology|November 30, 2011
Advances in coeliac diseaseMatthew J Armstrong, Vinod S Hegade, Gerry Robins
Hepatobiliary Surgery and Nutrition|May 11, 2018
Beyond the liver in patients with non-alcoholic fatty liver disease (NAFLD)-cause for concern?Matthew J Armstrong, Geoffrey Haydon, Wing-Kin Syn
Alimentary Pharmacology & Therapeutics|August 28, 2020
Editorial: current challenges in predicting mortality in patients with cirrhosis and refractory ascitesSara Mahgoub, Matthew J Armstrong, James W Ferguson
JAMA|February 18, 2015
Fecal microbiota transplantation for Clostridium difficile infectionMatthew J Armstrong, Shrikanth Pathmakanthan, Tariq H Iqbal
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2021
Safety and Efficacy of Glucagon-like Peptide 1 Receptor Agonists in Patients With CirrhosisSean M Morris, Matthew J Armstrong, Philip N Newsome
The American Journal of Gastroenterology|September 9, 2014
NAFLD is underrecognized in the primary care setting: UK experienceMatthew J Armstrong, Diarmaid D Houlihan, Philip N Newsome
Pageof 12

Showing results (11-20 of 120) with videos related to

Sort By:
Pageof 12
Gastroenterology|September 27, 2017
Dysphagia: More Than Meets the Eye?Matthew J Armstrong, Ruhina Ahmed, Ralph Boulton
Lancet (London, England)|June 18, 2016
Liraglutide for patients with non-alcoholic steatohepatitis - Authors' replyPhilip N Newsome, Matthew J Armstrong, Piers Gaunt
Hepatology (Baltimore, Md.)|June 12, 2016
Identifying patients with nonalcoholic steatohepatitis that are nonresponders to therapyMatthew J Armstrong, Piers Gaunt, Philip N Newsome
BJGP Open|December 21, 2023
How to address the inverse care law and increase GP recruitment in areas of socioeconomic deprivation: a qualitative study of GP trainees' views and experiences in the UKMatthew J Armstrong, Josephine M Wildman, Sarah Sowden
Current Opinion in Gastroenterology|November 30, 2011
Advances in coeliac diseaseMatthew J Armstrong, Vinod S Hegade, Gerry Robins
Hepatobiliary Surgery and Nutrition|May 11, 2018
Beyond the liver in patients with non-alcoholic fatty liver disease (NAFLD)-cause for concern?Matthew J Armstrong, Geoffrey Haydon, Wing-Kin Syn
Alimentary Pharmacology & Therapeutics|August 28, 2020
Editorial: current challenges in predicting mortality in patients with cirrhosis and refractory ascitesSara Mahgoub, Matthew J Armstrong, James W Ferguson
JAMA|February 18, 2015
Fecal microbiota transplantation for Clostridium difficile infectionMatthew J Armstrong, Shrikanth Pathmakanthan, Tariq H Iqbal
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2021
Safety and Efficacy of Glucagon-like Peptide 1 Receptor Agonists in Patients With CirrhosisSean M Morris, Matthew J Armstrong, Philip N Newsome
The American Journal of Gastroenterology|September 9, 2014
NAFLD is underrecognized in the primary care setting: UK experienceMatthew J Armstrong, Diarmaid D Houlihan, Philip N Newsome
Pageof 12